
Developer of a gene therapy designed to maintain and restore sight in patients with inherited retinal dystrophies. The company's gene therapy is potentially a sight restoring therapy for a rare degenerative disease causing blindness known as Choroideremia, enabling patients to get treated for several rare conditions caused by mutations in a single gene.

Tell NightstaRx you're interested in working at the company, while keeping your personal identity anonymous. Comparably will give NightstaRx the opportunity to hire you. When there's a job opening that's a fit we'll make the match happen.
Send them an invite to rate the company culture.